Laboratorios Farmaceuticos ROVI SA
Laboratorios Farmaceuticos ROVI's GHG Emissions Data Preview
In 2024, Laboratorios Farmaceuticos ROVI completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Laboratorios Farmaceuticos ROVI has also provided a category-level breakdown for 6 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
aVerified Sources Behind Laboratorios Farmaceuticos ROVI’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Laboratorios Farmaceuticos ROVI’s data sources below and access millions more through our Disclosure Search.
Insights into Laboratorios Farmaceuticos ROVI's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Laboratorios Farmaceuticos ROVI amounted to 18,808.98 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Laboratorios Farmaceuticos ROVI increased by 13.11%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
Laboratorios Farmaceuticos ROVI's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Laboratorios Farmaceuticos ROVI's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Laboratorios Farmaceuticos ROVI were 9,565.8 metric tons of CO₂ equivalent (tCO₂e). a
Has Laboratorios Farmaceuticos ROVI reduced its Scope 1 emissions over time?
Since 2021, Laboratorios Farmaceuticos ROVI's Scope 1 emissions have increased by 53.54%, reflecting a rising long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2023), Laboratorios Farmaceuticos ROVI's Scope 1 emissions increased by 16.08%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
What are Laboratorios Farmaceuticos ROVI's Scope 2 emissions?
In 2024, Laboratorios Farmaceuticos ROVI reported Scope 2 greenhouse gas (GHG) emissions of 37.46 tCO₂e using the market-based method and 9,243.18 tCO₂e using the location-based method. a
Has Laboratorios Farmaceuticos ROVI reduced its Scope 2 emissions over time?
Compared to the previous year (2023), Laboratorios Farmaceuticos ROVI's Scope 2 emissions (Location-Based) rose by 10.18% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
What methodology does Laboratorios Farmaceuticos ROVI use for Scope 2 reporting?
In 2024, Laboratorios Farmaceuticos ROVI reported its Scope 2 emissions using the market-based method and using the location-based method. a
Laboratorios Farmaceuticos ROVI's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
- Total Scope 2 (Unspecified Calculation Method)
Insights into Laboratorios Farmaceuticos ROVI's Value Chain Emissions
In 2024, Laboratorios Farmaceuticos ROVI reported 12,099.63 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2024 disclosure of Laboratorios Farmaceuticos ROVI includes a breakdown across 6 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
Laboratorios Farmaceuticos ROVI's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Laboratorios Farmaceuticos ROVI's Scope 3 emissions?
In 2024, Laboratorios Farmaceuticos ROVI reported total Scope 3 emissions of 12,099.63 metric tons of CO₂ equivalent (tCO₂e). a
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment. a
Compared to the previous year (2023), Laboratorios Farmaceuticos ROVI's Scope 3 emissions increased by 16.93%, suggesting that the company faced challenges in reducing emissions across its value chain. a
What categories of Scope 3 emissions does Laboratorios Farmaceuticos ROVI disclose?
In 2024, Laboratorios Farmaceuticos ROVI reported emissions for 6 out of the 15 Scope 3 categories defined by the GHG Protocol. a
This partial disclosure allows for some insight into the company's indirect impacts.
What are the main sources of Laboratorios Farmaceuticos ROVI's Scope 3 emissions?
In 2024, the largest contributors to Laboratorios Farmaceuticos ROVI's Scope 3 emissions were: a
- Purchased Goods and Services (Cat. 1): 5,186.28 tCO₂e (42.86%)
- Waste Generated in Operations (Cat. 5): 3,352.12 tCO₂e (27.7%)
- Employee Commuting (Cat. 7): 2,377.91 tCO₂e (19.65%)
Laboratorios Farmaceuticos ROVI's Scope 3 Emissions by Categories
Insights into Laboratorios Farmaceuticos ROVI’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Laboratorios Farmaceuticos ROVI reported Scope 1 greenhouse gas (GHG) emissions of 9,565.8 tCO₂e and total revenues of USD 795 millions. This translates into an emissions intensity of 12.04 tCO₂e per millions USD. a
Laboratorios Farmaceuticos ROVI's Scope 1 Emissions Intensity Compared to Peers
How does Laboratorios Farmaceuticos ROVI's GHG emissions intensity compare to its peers?
In 2024, Laboratorios Farmaceuticos ROVI reported a Scope 1 emissions intensity of 12.04 tCO₂e per millions USD. Compared to the peer group median of 14.56 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
Where does Laboratorios Farmaceuticos ROVI rank on GHG emissions intensity within its industry?
In 2024, Laboratorios Farmaceuticos ROVI ranked 11 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
Laboratorios Farmaceuticos ROVI is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a
Insights into Laboratorios Farmaceuticos ROVI's Total Carbon Footprint
In 2024, Laboratorios Farmaceuticos ROVI reported a total carbon footprint of 30,908.61 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 14.57% increase compared to 2023, suggesting a rise in emissions across its operations or value chain. a
The largest contributor to Laboratorios Farmaceuticos ROVI's total carbon footprint was Scope 3 emissions, accounting for 39.15% of the company's total carbon footprint, followed by Scope 1 emissions at 30.95%. a